Akari Ishitsuka
Research Subjects
Research Interests
Akari Ishitsuka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Akira Shibuya
University of Tsukuba
1 shared publication - Atsushi Kawaguchi
Department of Infection Biology, Institute of Medicine, University of Tsukuba
1 shared publication - Kyosuke Nagata
Department of Infection Biology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Ibaraki, Japan
1 shared publication - SangJoon Lee
Department of Biological Science, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea
1 shared publication - Takahiro Kuroki
Graduate School of Comprehensive Human Sciences
1 shared publication - Tsunaki Hongu
Department of Physiological Chemistry, Faculty of Medicine
1 shared publication
Latest Publications
- Open Access
- 23 August 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (16)
Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes
Asthma is a chronic inflammatory disease of the airways associated with excess production of Th2 cytokines and lung eosinophil accumulation. This inflammatory response persists in spite of steroid administration that blocks autocrine/paracrine loops of inflammatory cytokines, and the detailed mechanisms underlying asthma exacerbation remain unclear. Here, we show that asthma exacerbation is triggered by airway macrophages through a prion-like cell-to-cell transmission of extracellular particulates, including ASC protein, that assemble inflammasomes and mediate IL-1β production. OVA-induced allergic asthma and associated IL-1β production were alleviated in mice with small GTPase Arf6 -deficient macrophages. The extracellular ASC specks were slightly engulfed by Arf6 –/– macrophages, and the IL-1β production was reduced in Arf6 –/– macrophages compared with that in WT macrophages. Furthermore, pharmacological inhibition of the Arf6 guanine nucleotide exchange factor suppressed asthma-like allergic inflammation in OVA-challenged WT mice. Collectively, the Arf6-dependent intercellular transmission of extracellular ASC specks contributes to the amplification of allergic inflammation and subsequent asthma exacerbation.
- 23 August 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (16)
Open AccessArf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes
Asthma is a chronic inflammatory disease of the airways associated with excess production of Th2 cytokines and lung eosinophil accumulation. This inflammatory response persists in spite of steroid administration that blocks autocrine/paracrine loops of inflammatory cytokines, and the detailed mechanisms underlying asthma exacerbation remain unclear. Here, we show that asthma exacerbation is triggered by airway macrophages through a prion-like cell-to-cell transmission of extracellular particulates, including ASC protein, that assemble inflammasomes and mediate IL-1β production. OVA-induced allergic asthma and associated IL-1β production were alleviated in mice with small GTPase Arf6 -deficient macrophages. The extracellular ASC specks were slightly engulfed by Arf6 –/– macrophages, and the IL-1β production was reduced in Arf6 –/– macrophages compared with that in WT macrophages. Furthermore, pharmacological inhibition of the Arf6 guanine nucleotide exchange factor suppressed asthma-like allergic inflammation in OVA-challenged WT mice. Collectively, the Arf6-dependent intercellular transmission of extracellular ASC specks contributes to the amplification of allergic inflammation and subsequent asthma exacerbation.